Menu
Virtual Human Platform Logo

The Virtual
Human Platform

Safety assessment of chemicals and pharmaceuticals using human data-driven tools and case studies.

Case Studies
See how tools, methods and data combine to answer regulatory questions.
Tools
Select an in silico tool to streamline your safety assessment.
Methods
Select an in vitro method to perform your safety assessment.
Data
Find the (meta)data you need for tools and workflows.

Virtual Human Platform

A digital infrastructure for animal-free safety assessment.

The Virtual Human Platform (VHP) is a digital infrastructure that supports human-relevant risk assessment of chemicals and pharmaceuticals. By integrating human-derived data, advanced in vitro models, and computational tools, the VHP enables transparent, reproducible and mechanistically informed safety assessment moving beyond traditional animal testing.

Through structured, interactive workflows and a user-friendly interface, the platform tackles real-world regulatory questions ('case studies') by connecting tools, methods and data.


Safety Assessment Workflow

The Virtual Human Platform uses a generic safety assessment workflow as a five-step process to collect information critical for risk characterisation.


Case studies

On the platform, three human relevant case studies are used as demonstrators:

These case studies show how multiple New Approach Methodologies (NAMs) can be combined to address regulatory challenges and illustrate practices concerning data, model assumptions, and interpretation.


Learn more about VHP4Safety, the project behind the VHP

Developed in co-creation with academic, industrial, regulatory, and societal partners, the VHP supports the transition to animal-free, human-relevant safety assessment. We invite all stakeholders to explore, contribute, and help shape the future of risk assessment with us.

Supported by

Collaboration in innovation.

Connect with us

Got questions, need support or just want to chat?

Use the form below, or contact us on LinkedIn, GitHub, or via email and we’ll get back to you as soon as possible.